[go: up one dir, main page]

MX2010012730A - Metodo para diferenciacion de celulas progenitoras de mamifero en celulas de islote pancreaticas que producen insulina. - Google Patents

Metodo para diferenciacion de celulas progenitoras de mamifero en celulas de islote pancreaticas que producen insulina.

Info

Publication number
MX2010012730A
MX2010012730A MX2010012730A MX2010012730A MX2010012730A MX 2010012730 A MX2010012730 A MX 2010012730A MX 2010012730 A MX2010012730 A MX 2010012730A MX 2010012730 A MX2010012730 A MX 2010012730A MX 2010012730 A MX2010012730 A MX 2010012730A
Authority
MX
Mexico
Prior art keywords
cells
pancreatic islet
insulin producing
producing pancreatic
progenitor cells
Prior art date
Application number
MX2010012730A
Other languages
English (en)
Inventor
Steven Michael Hoynowski
Joseph Charles Ruiz
Original Assignee
Vesta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vesta Therapeutics Inc filed Critical Vesta Therapeutics Inc
Publication of MX2010012730A publication Critical patent/MX2010012730A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/507—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/065—Modulators of histone acetylation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/14—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)

Abstract

La invención se refiere a métodos para diferenciar células progenitoras en células de islote pancreáticas que producen insulina y composición y métodos para usar tales células.
MX2010012730A 2008-05-22 2009-05-21 Metodo para diferenciacion de celulas progenitoras de mamifero en celulas de islote pancreaticas que producen insulina. MX2010012730A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5534108P 2008-05-22 2008-05-22
PCT/US2009/044856 WO2009143353A1 (en) 2008-05-22 2009-05-21 Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells

Publications (1)

Publication Number Publication Date
MX2010012730A true MX2010012730A (es) 2011-03-01

Family

ID=40983494

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010012730A MX2010012730A (es) 2008-05-22 2009-05-21 Metodo para diferenciacion de celulas progenitoras de mamifero en celulas de islote pancreaticas que producen insulina.

Country Status (14)

Country Link
US (3) US8877497B2 (es)
EP (1) EP2291514B1 (es)
JP (1) JP2011520470A (es)
KR (1) KR20110051166A (es)
CN (1) CN102282250A (es)
AU (1) AU2009248959A1 (es)
BR (1) BRPI0912320A2 (es)
CA (1) CA2725196A1 (es)
ES (1) ES2862623T3 (es)
IL (1) IL209471A0 (es)
MX (1) MX2010012730A (es)
RU (1) RU2010152354A (es)
TW (1) TW201000110A (es)
WO (1) WO2009143353A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2725196A1 (en) * 2008-05-22 2009-11-26 Vesta Therapeutics, Inc. Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells
CN103124787B (zh) 2010-10-05 2015-04-29 宝生物工程株式会社 制造病毒载体的方法
KR101307196B1 (ko) * 2011-07-15 2013-09-12 국립대학법인 울산과학기술대학교 산학협력단 미세 세포 배양 장치
EP2829606A4 (en) * 2012-03-22 2016-02-24 Takara Bio Inc PROCESS FOR PRODUCING VIRAL VECTOR
WO2015190522A1 (ja) * 2014-06-12 2015-12-17 国立大学法人京都大学 内胚葉性幹細胞の製造方法
CN110392735A (zh) * 2017-01-17 2019-10-29 新加坡科技研究局 胰腺祖细胞的维持和扩增
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6069005A (en) 1991-08-07 2000-05-30 Albert Einstein College Of Medicine Of Yeshwa University Hapatoblasts and method of isolating same
US5919702A (en) 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
GB2328443B (en) * 1997-08-21 2001-09-05 Reckitt & Colmann Prod Ltd In situ formation of pharmaceutically acceptable polymeric material
WO1999028444A1 (en) 1997-12-02 1999-06-10 Zen Bio, Inc. Differentiation of adipose stromal cells into osteoblasts and uses thereof
ATE414143T1 (de) 1999-01-19 2008-11-15 Univ North Carolina Menschliche leber-vorläuferzellen
US7001746B1 (en) 1999-01-29 2006-02-21 Artecel Sciences, Inc. Methods and compositions for the differentiation of human preadipocytes into adipocytes
US6153432A (en) 1999-01-29 2000-11-28 Zen-Bio, Inc Methods for the differentiation of human preadipocytes into adipocytes
US6429013B1 (en) 1999-08-19 2002-08-06 Artecel Science, Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US6555374B1 (en) 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
US7456017B2 (en) 1999-10-01 2008-11-25 University Of North Carolina At Chapel Hill Processes for clonal growth of hepatic progenitor cells
US6610535B1 (en) * 2000-02-10 2003-08-26 Es Cell International Pte Ltd. Progenitor cells and methods and uses related thereto
US20050053588A1 (en) 2001-10-18 2005-03-10 Li Yin Conversion of liver stem and progenitor cells to pancreatic functional cells
GB2399823B (en) * 2001-12-07 2006-02-15 Geron Corp Islet cells from primate pluripotent stem cells
US7736892B2 (en) 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
CN104630129A (zh) 2002-03-15 2015-05-20 北卡罗来纳大学查伯山分校 原肝干细胞和近肝干细胞
US20040002447A1 (en) 2002-06-04 2004-01-01 Regents Of The University Of California Induction of insulin expression
CN1536075A (zh) * 2003-04-09 2004-10-13 中国人民解放军军事医学科学院野战输 一种诱导骨髓间充质干细胞向胰岛样细胞分化的方法
WO2006045331A1 (en) * 2004-10-27 2006-05-04 Vrije Universiteit Brussel Differentiation of stem cells and stabilization of phenotypical properties of primary cells
KR20080097985A (ko) 2005-11-16 2008-11-06 유니버시티 오브 노스캐롤라이나 앳 채플 힐 간 전구체의 확대 또는 분화를 위한 세포외 매트릭스 성분
US8586530B2 (en) * 2006-04-27 2013-11-19 University Of South Florida Modulation of inhibition of ferrochelatase by N-methyl protoporphyrin
US8741643B2 (en) * 2006-04-28 2014-06-03 Lifescan, Inc. Differentiation of pluripotent stem cells to definitive endoderm lineage
WO2008002662A2 (en) 2006-06-28 2008-01-03 The Univeristy Of Kansas Differentiation of stem cells from umbilical cord matrix into hepatocyte lineage cells
US20080063628A1 (en) * 2006-09-11 2008-03-13 Davis Janet E Methods to promote cell differentiation
CA2725196A1 (en) * 2008-05-22 2009-11-26 Vesta Therapeutics, Inc. Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells

Also Published As

Publication number Publication date
US20170045497A1 (en) 2017-02-16
CA2725196A1 (en) 2009-11-26
US9605244B2 (en) 2017-03-28
EP2291514B1 (en) 2020-12-23
CN102282250A (zh) 2011-12-14
IL209471A0 (en) 2011-01-31
US8877497B2 (en) 2014-11-04
WO2009143353A1 (en) 2009-11-26
TW201000110A (en) 2010-01-01
RU2010152354A (ru) 2012-06-27
US20150056647A1 (en) 2015-02-26
BRPI0912320A2 (pt) 2015-08-04
KR20110051166A (ko) 2011-05-17
ES2862623T3 (es) 2021-10-07
JP2011520470A (ja) 2011-07-21
EP2291514A1 (en) 2011-03-09
AU2009248959A1 (en) 2009-11-26
US20100136688A1 (en) 2010-06-03

Similar Documents

Publication Publication Date Title
PH12013500349A1 (en) Differentiation of pluripotent stem cells
EP4410991A3 (en) Differentiation of human embryonic stem cells
MX349178B (es) Diferenciación de células madre embrionarias humanas al linaje endocrino pancreático.
MX2010012730A (es) Metodo para diferenciacion de celulas progenitoras de mamifero en celulas de islote pancreaticas que producen insulina.
WO2009137844A3 (en) Pancreatic endocrine progenitor cells derived from pluripotent stem cells
MX2009000023A (es) Diferenciacion de celulas madre de matriz de cordon umbilical en celulas de linaje hepatocitico.
MY169317A (en) Methods for converting lignocellulosic material to useful products
EP2633036A4 (en) DIFFERENTIATION METHOD FOR THE PRODUCTION OF GLIA CELL POPULATIONS
MY161726A (en) Biological methods for preparing adipic acid
MY156588A (en) Systems using cell culture for production of isoprene
MX2010012298A (es) Activadores de glucocinasa.
MY173663A (en) Compositions and methods for biological production of fatty acid derivatives
MX339669B (es) Diferenciacion de celulas madres embrionarias humanas.
GB2527254A (en) Benzylisoquinoline alkaloids (BIA) Producing microbes, and methods of making and using the same
GB2485112A (en) Differentiation of human embryonic stem cells
IN2012DN00462A (es)
SG10201810830UA (en) Cell culture compositions and methods for polypeptide production
MX2008014692A (es) Metodo de cultivo para obtener una poblacion clonal de celulas b especificas de antigeno.
ATE500327T1 (de) Verfahren und zusammensetzungen für ethanolproduzierende cyanobakterien
AU2014300650B2 (en) Cell populations, methods of transdifferention and methods of use thereof
WO2010093655A3 (en) Enhanced method for producing stem-like cells from somatic cells
NZ607149A (en) Galacto-oligosaccharide-containing composition and a method of producing it
PH12014502870A1 (en) Method of producing recombinant iduronate-2-sulfatase
SI2352835T1 (sl) Clostridium sporosphaeroides za proizvodnjo bioplina iz biomase
MX2010007945A (es) Preparacion y transplante de celulas de isletas pancreaticas.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal